Actinium Pharmaceuticals, Inc. (NYSE: ATNM) announced today that it has filed a preliminary prospectus supplement as a part of a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE